Mumbai, May 13 (IANS) Domestic equity markets opened flat on Wednesday amid mixed global cues and a decline in oil prices.Sensex was trading at 74,567, up 8 points or 0.01 per cent, while the Nifty was at 23,387, gaining 8 points or 0.03 per cent. Earlier in the day, the benchmark indices opened at 74,439.34 and 23,362.45, respectively.Among sectoral indices, Nifty IT and Nifty Media were the top losers, while Nifty Metal, Nifty FMCG and Nifty Chemicals emerged as the top gainers.Eicher Motors, …
Latest Dr Reddy’s Laboratories News & Updates
Mumbai, May 12 (IANS) Indian equity benchmarks traded sharply lower on Tuesday for the second consecutive day in morning trade, with both indices declining around 0.5 per cent amid geopolitical tensions.Sensex declined as much as 0.62 per cent or 474 points to trade at an intraday low of 75,541 in early trade, while Nifty was seen trading at 23,689, down 0.53 per cent or 126 points from the previous close.Sector-wise, IT, chemicals, realty, cement and financial indices were among the top losers,…
Mumbai, May 11 (IANS) Indian equity markets traded cautiously on Monday, with benchmark indices falling 1 per cent each in early trade after the US and Iran failed to reach an agreement on a peace proposal related to the West Asia conflict.Sensex declined as much as 943 points or 1.22 per cent to hit an intraday low of 76,384 in morning trade, while Nifty fell 280 points or 1.15 per cent to 23,897.Sectorally, all indices traded in the red, with Nifty Consumer Durables, Nifty Auto, Nifty PSU Bank…
Mumbai, May 4 (IANS) Indian equity benchmarks opened on a strong note on Monday, with indices gaining 1 per cent each in the morning trade, aided by softer crude oil prices amid indications of easing tensions in West Asia amid early Assembly election trends in key states.Sensex surged as much as 833 points or 1.08 per cent to hit an intraday high of 77,746.79 in early deals, while Nifty touched 24,245.85, up 250 points or 1.03 per cent.On the sectoral front, buying interest was seen across auto,…
Mumbai, April 29 (IANS) Domestic equity markets traded higher on Wednesday despite a rise in crude oil prices and reports that the United States may extend its blockade of Iranian ports.Sensex traded 0.52 per cent, or 400 points, higher at 77,289.55, hitting an intraday high in early trade, while Nifty rose 0.53 per cent, or 127.8 points, to 24,123.55.Sector-wise, buying interest was seen in auto, chemicals, realty, energy and IT stocks.Nifty Auto, Nifty Chemicals, Nifty Realty, Nifty Oil & …
Mumbai, April 24 (IANS) The domestic equity markets saw negative performance in early hours on Friday amid elevated geopolitical tensions and the Q4 earnings season.Sensex was trading at 77,263, down 0.51 per cent or 400 points, while Nifty was down 0.41 per cent, or 100 points, in early trade amid panic selling in IT, financial and pharma stocks. However, support was seen in FMCG and chemical scrips.Cipla, Infosys, Dr Reddy’s Laboratories, Sun Pharma, TCS and ICICI Bank were among the top lag…
Mumbai, April 3 (IANS) Indian equity markets closed lower for the sixth consecutive week amid escalating geopolitical tensions in West Asia and sharp currency fluctuations, with both headline indices ending in the red during a shortened four-day trading week.Sensex ended at 73,319.55 on Thursday, down 263.67 points or 0.35 per cent, compared to the previous Friday’s close. Nifty 50 settled at 22,713.10, a decline of 106.50 points or 0.46 per cent on a week-on-week basis.In the final session of t…
New Delhi, March 27 (IANS) Major drug maker Dr. Reddy’s Laboratories on Friday told the Delhi High Court that it will change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’, a report said on Friday.The company informed the court that it would propose a new brand name following the judge’s observation that the existing name could lead to confusion in a pharmaceutical setting.The dispute comes as India opens up to generic versions of semaglutide following patent expiry, trigg…
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Mumbai, Jan 28 (IANS) Indian equity benchmark indices Sensex and Nifty ended Wednesday’s session with modest gains, managing to stay in the green despite sharp volatility through the day. Investor sentiment was influenced by December-quarter earnings announcements and the finalisation of the India–European Union Free Trade Agreement.The Sensex closed at 82,345, rising 487 points, or 0.60 per cent. During the session, the index moved between a high of 82,504 and a low of 81,815 as markets swu…